Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 July 2025 : Review article  

Advances in Neuromodulation Techniques for Aphasia Rehabilitation: A Comprehensive Review

Jiayi Xia ADEFG 1, Yeping Chen BCFG 1, Song Pei ADEF 2*, Chunlei Shan ADEF 3,4,5, Jingjing Zhang EF 3, Zhiqing Zhou EF 3, Jiali Wu EF 3, Yao Lu BC 1, Yiyi Chen BC 1, Yunjia Chen DF 1

DOI: 10.12659/MSM.947213

Med Sci Monit 2025; 31:e947213

Table 1 Comparison of transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), and mirror neuron system (MNS) therapy in aphasia rehabilitation.

CharacteristicsTranscranial Direct Current Stimulation (tDCS)Transcranial Magnetic Stimulation (TMS)Mirror Neuron System (MNS) therapy
Non-invasivenessYesYesYes
Primary mechanism of actionModulates cortical excitability via low-intensity direct current to enhance neural plasticityInduces electrical currents via magnetic fields to modulate cortical excitability (excitation/inhibition)Activates language-related neural circuits through action observation and imitation
Primary treatment targetsLeft hemisphere language areas (eg, inferior frontal gyrus, IFG) or inhibitory modulation of right hemisphere homologous regionsCortical areas (eg, Broca’s area, right IFG) with precise frequency-based modulationSensorimotor language networks involving Broca’s and Wernicke’s areas
Integration with speech therapyCommonly combined with behavioral language therapy for synergistic effectsOften used with neuronavigation and speech therapyApplied with action observation-execution paradigms to support language recovery
Typical treatment parameters1–2 mA current, 20–30 min per sessionLow-frequency (≤1 Hz) inhibitory or high-frequency (≥5 Hz) excitatory protocolsMultiple action observation and imitation sessions per week
IndicationsPrimarily post-stroke aphasia (PSA), emerging in primary progressive aphasia (PPA)PSA (chronic and subacute), exploratory use in PPAPSA with motor-language impairment focus
Safety profileHighly safe, with no reported cases of seizure induction; side effects are generally limited to mild skin discomfortGenerally safe, though rarely may induce seizures; possible transient side effects include headaches or scalp discomfortSafe, as it mainly involves cognitive engagement through action observation, without causing physical discomfort
Target areasPrimarily targets cortical language regions, such as the left hemisphere language areas or right hemisphere inhibitory areasPrimarily targets cortical regions with limited penetration depth (approximately 1–3 cm beneath the scalp), but remain insufficient to precisely target deep brain structuresFocuses on motor neuron systems involved in language processing, including Broca’s and Wernicke’s areas
Treatment efficacyResearch shows significant improvements in naming ability and speech recoveryTMS has been shown to effectively improve naming and speech functionMNS Therapy has demonstrated efficacy in promoting language recovery in aphasia patients through action imitation
LimitationsOptimization of stimulation intensity, duration, and electrode placement is needed to account for individual variabilityVariability in stimulation site, frequency selection, and individual responsesLimited effectiveness for language recovery not related to motor functions, with effects potentially task-specific
tDCS – transcranial direct current stimulation; TMS – transcranial magnetic stimulation; MNS – mirror neuron system; IFG – inferior frontal gyrus; PSA – post-stroke aphasia; PPA – primary progressive aphasia.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750